CSF1R and ovarian carcinoma: Second, numerous studies have demonstrated that CSF-1R also drives tumor cell progression in several cancer types, including renal cell carcinoma [43], ovarian cancer [44], colorectal cancer [45], bladder cancer [46], mesothelioma [47], and melanoma [48].